Their lead drug candidate, micvotabart pelidotin (MICVO) , has received FDA Fast Track Designation for head and neck cancer. Preliminary Phase 1 clinical data is expected to be a major "make-or-break" milestone in late 2025 and through 2026. Zentalis Pharmaceuticals (ZNTL) Sector: Healthcare (Biotechnology) Current Price: Approximately $3.74
These stocks can experience rapid price swings based on a single news event. stocks to buy under 5
Valens specializes in high-speed connectivity for automotive and audio-video markets. It recently secured three new design wins with European automotive manufacturers for vehicles starting production in 2026. The company is debt-free with a solid cash position of approximately $94 million . Pyxis Oncology (PYXS) Sector: Healthcare (Biotechnology) Current Price: Approximately $1.76 Their lead drug candidate, micvotabart pelidotin (MICVO) ,
AI responses may include mistakes. For financial advice, consult a professional. Learn more consult a professional. Learn more